Class information for:
Level 1: INFLAMMATORY BREAST CANCER//NEOADJUVANT CHEMOTHERAPY//LOCALLY ADVANCED BREAST CANCER

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
3052 1999 32.1 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
276 18466 BREAST CANCER//ACCELERATED PARTIAL BREAST IRRADIATION//PARTIAL BREAST IRRADIATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INFLAMMATORY BREAST CANCER Author keyword 135 61% 7% 145
2 NEOADJUVANT CHEMOTHERAPY Author keyword 97 21% 21% 418
3 LOCALLY ADVANCED BREAST CANCER Author keyword 95 56% 6% 114
4 PRIMARY CHEMOTHERAPY Author keyword 29 47% 2% 46
5 PATHOLOGICAL COMPLETE RESPONSE Author keyword 29 43% 3% 51
6 PATHOLOGIC COMPLETE RESPONSE Author keyword 28 41% 3% 53
7 PRIMARY SYSTEMIC THERAPY Author keyword 28 64% 1% 27
8 BREAST MED ONCOL Address 14 10% 6% 129
9 NEOADJUVANT Author keyword 14 14% 5% 97
10 INFLAMMATORY BREAST CARCINOMA Author keyword 14 57% 1% 16

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 INFLAMMATORY BREAST CANCER 135 61% 7% 145 Search INFLAMMATORY+BREAST+CANCER Search INFLAMMATORY+BREAST+CANCER
2 NEOADJUVANT CHEMOTHERAPY 97 21% 21% 418 Search NEOADJUVANT+CHEMOTHERAPY Search NEOADJUVANT+CHEMOTHERAPY
3 LOCALLY ADVANCED BREAST CANCER 95 56% 6% 114 Search LOCALLY+ADVANCED+BREAST+CANCER Search LOCALLY+ADVANCED+BREAST+CANCER
4 PRIMARY CHEMOTHERAPY 29 47% 2% 46 Search PRIMARY+CHEMOTHERAPY Search PRIMARY+CHEMOTHERAPY
5 PATHOLOGICAL COMPLETE RESPONSE 29 43% 3% 51 Search PATHOLOGICAL+COMPLETE+RESPONSE Search PATHOLOGICAL+COMPLETE+RESPONSE
6 PATHOLOGIC COMPLETE RESPONSE 28 41% 3% 53 Search PATHOLOGIC+COMPLETE+RESPONSE Search PATHOLOGIC+COMPLETE+RESPONSE
7 PRIMARY SYSTEMIC THERAPY 28 64% 1% 27 Search PRIMARY+SYSTEMIC+THERAPY Search PRIMARY+SYSTEMIC+THERAPY
8 NEOADJUVANT 14 14% 5% 97 Search NEOADJUVANT Search NEOADJUVANT
9 INFLAMMATORY BREAST CARCINOMA 14 57% 1% 16 Search INFLAMMATORY+BREAST+CARCINOMA Search INFLAMMATORY+BREAST+CARCINOMA
10 PATHOLOGICAL RESPONSE 9 34% 1% 23 Search PATHOLOGICAL+RESPONSE Search PATHOLOGICAL+RESPONSE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 COMBINED MODALITY APPROACH 150 92% 3% 59
2 PREOPERATIVE CHEMOTHERAPY 133 20% 30% 595
3 PROJECT PROTOCOL B 27 89 63% 5% 90
4 CHEMOENDOCRINE THERAPY 67 75% 2% 48
5 SURGICAL ADJUVANT BREAST 47 13% 17% 334
6 CARCINOMA INCIDENCE 42 74% 2% 31
7 SYSTEMIC TREATMENT 41 38% 4% 85
8 INDUCTION CHEMOTHERAPY 35 13% 13% 259
9 INTERNATIONAL EXPERT PANEL 34 60% 2% 37
10 III RANDOMIZED GEPARTRIO 31 61% 2% 33

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment 2011 85 47 66%
Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy 2013 21 60 78%
HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials 2013 25 52 63%
Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients 2011 46 24 83%
Preoperative therapy in invasive breast cancer: Pathologic assessment and systemic therapy issues in operable disease 2008 118 37 73%
INFLAMMATORY BREAST-CANCER - A REVIEW 1992 200 30 90%
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006 2007 140 59 54%
Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer 2011 40 59 59%
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies 2014 7 44 82%
Pathology of Breast Carcinomas After Neoadjuvant Chemotherapy An Overview With Recommendations on Specimen Processing and Reporting 2009 32 31 81%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BREAST MED ONCOL 14 10% 6.5% 129
2 MORGAN WELCH INFLAMMATORY BREAST CANC PROGRAM 7 35% 0.9% 17
3 BUR RECH CLIN 7 64% 0.4% 7
4 GERMAN BREAST GRP 6 29% 0.9% 18
5 SENOL 5 10% 2.1% 42
6 UNIT MED SENOL 4 21% 0.8% 15
7 DIRECT RECH THER EUT 3 100% 0.2% 3
8 ONCOGENET E0017 3 60% 0.2% 3
9 UNIT 1354 2 13% 0.8% 16
10 MED PHYS ADV RADIOTHER Y 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000145195 B2T//BREAST DIS UNIT//POSITRON EMISSION MAMMOGRAPHY
2 0.0000124369 ONCOTYPE DX//TRIPLE NEGATIVE BREAST CANCER//TRIPLE NEGATIVE
3 0.0000085969 TRASTUZUMAB//LAPATINIB//PERTUZUMAB
4 0.0000085152 METASTATIC BREAST CANCER//VINORELBINE//DOCETAXEL
5 0.0000085132 HIGH DOSE CHEMOTHERAPY//DOSE INTENSITY//HIGH RISK BREAST CANCER
6 0.0000077548 BREAST MRI//BREAST NEOPLASMS MR//MR MAMMOGRAPHY
7 0.0000074785 HER 2//HER2 TESTING//POLYSOMY 17
8 0.0000067512 TSU 68//APATINIB//MUCOCUTANEOUS TOXICITIES
9 0.0000060096 PEGFILGRASTIM//FEBRILE NEUTROPENIA//FILGRASTIM
10 0.0000050602 AROMATASE INHIBITORS//EXEMESTANE//ANASTROZOLE